Latest News

UNC Selects MedAssurant to Support Investigation of Relationship Between Insulin and Cancer Development

BOWIE, Md. Feb. 3, 2011 University of North Carolina UNC UNC

Recent publications have suggested a relationship may exist between a specific type of prescription long-acting insulin and increased rates of cancer development.  Due to the inconsistent findings within these previous publications, this study is designed to further clarify the possible correlation using several very large and statistically powerful clinical and administrative healthcare databases, including MedAssurant’s MORE2 Registry.  As one of the most significant healthcare datasets available for such analysis, the MORE2 Registry contains more than 3.9 billion medical events from more than 76 million patients, 295,000 physicians, and 185,000 clinical facilities – enabling significant power and insight into the investigation of advancements in healthcare.

MedAssurant will be responsible for coordinating the identification of specific cohorts within the MORE2 Registry, the evaluation of clinical covariates that may affect incidences of cancer, and the application of advanced clinical analytics to assess the relationship between prescription insulin and cancer development.

John Buse UNC

Stephen DeCherney UNC

About MedAssurant, Inc.


Russo Partners LLC on behalf of MedAssurant, Inc.

Tony Russo or Lena Evans

Phone: 212-845-4251

Phone: 212-845-4262

[email protected]

[email protected]

MedAssurant, Inc.

Alex Burgess

4321 Collington Road

Bowie, Maryland 20716

Phone: 301-809-4000

[email protected]

SOURCE MedAssurant, Inc.

Leave a comment

seks shop - izolasyon
basic theory test book basic theory test